deltex medical group plc
deltex medical group plc Company Information
Company Number
03902895
Next Accounts
Jun 2025
Shareholders
-
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
deltex medical terminus road, chichester, west sussex, PO19 8TX
Website
www.deltex.comdeltex medical group plc Estimated Valuation
Pomanda estimates the enterprise value of DELTEX MEDICAL GROUP PLC at £2.2m based on a Turnover of £1.8m and 1.26x industry multiple (adjusted for size and gross margin).
deltex medical group plc Estimated Valuation
Pomanda estimates the enterprise value of DELTEX MEDICAL GROUP PLC at £0 based on an EBITDA of £-919k and a 7.21x industry multiple (adjusted for size and gross margin).
deltex medical group plc Estimated Valuation
Pomanda estimates the enterprise value of DELTEX MEDICAL GROUP PLC at £7.3m based on Net Assets of £3.3m and 2.23x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Deltex Medical Group Plc Overview
Deltex Medical Group Plc is a live company located in west sussex, PO19 8TX with a Companies House number of 03902895. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in January 2000, it's largest shareholder is unknown. Deltex Medical Group Plc is a mature, small sized company, Pomanda has estimated its turnover at £1.8m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Deltex Medical Group Plc Health Check
Pomanda's financial health check has awarded Deltex Medical Group Plc a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
7 Weak
Size
annual sales of £1.8m, make it smaller than the average company (£17.8m)
£1.8m - Deltex Medical Group Plc
£17.8m - Industry AVG
Growth
3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (6.2%)
-10% - Deltex Medical Group Plc
6.2% - Industry AVG
Production
with a gross margin of 63.3%, this company has a lower cost of product (37.4%)
63.3% - Deltex Medical Group Plc
37.4% - Industry AVG
Profitability
an operating margin of -59.2% make it less profitable than the average company (6%)
-59.2% - Deltex Medical Group Plc
6% - Industry AVG
Employees
with 37 employees, this is below the industry average (90)
37 - Deltex Medical Group Plc
90 - Industry AVG
Pay Structure
on an average salary of £46.4k, the company has an equivalent pay structure (£49.5k)
£46.4k - Deltex Medical Group Plc
£49.5k - Industry AVG
Efficiency
resulting in sales per employee of £48k, this is less efficient (£179.4k)
£48k - Deltex Medical Group Plc
£179.4k - Industry AVG
Debtor Days
it gets paid by customers after 36 days, this is earlier than average (50 days)
36 days - Deltex Medical Group Plc
50 days - Industry AVG
Creditor Days
its suppliers are paid after 96 days, this is slower than average (35 days)
96 days - Deltex Medical Group Plc
35 days - Industry AVG
Stock Days
it holds stock equivalent to 401 days, this is more than average (95 days)
401 days - Deltex Medical Group Plc
95 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 39 weeks, this is more cash available to meet short term requirements (11 weeks)
39 weeks - Deltex Medical Group Plc
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 45.9%, this is a higher level of debt than the average (41.7%)
45.9% - Deltex Medical Group Plc
41.7% - Industry AVG
DELTEX MEDICAL GROUP PLC financials
Deltex Medical Group Plc's latest turnover from December 2023 is £1.8 million and the company has net assets of £3.3 million. According to their latest financial statements, Deltex Medical Group Plc has 37 employees and maintains cash reserves of £705 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 1,776,000 | 2,482,000 | 2,259,000 | 2,398,000 | 4,256,000 | 4,955,000 | 5,870,000 | 6,331,000 | 6,405,000 | 6,507,000 | 7,151,000 | 6,777,000 | 6,303,000 | 6,279,000 | 5,640,000 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 651,000 | 643,000 | 684,000 | 757,000 | 974,000 | 1,424,000 | 1,488,000 | 2,002,000 | 2,395,000 | 1,961,000 | 1,982,000 | 1,964,000 | 1,765,000 | 1,637,000 | 1,414,000 |
| Gross Profit | 1,125,000 | 1,839,000 | 1,575,000 | 1,641,000 | 3,282,000 | 3,531,000 | 4,382,000 | 4,329,000 | 4,010,000 | 4,546,000 | 5,169,000 | 4,813,000 | 4,538,000 | 4,642,000 | 4,226,000 |
| Admin Expenses | 2,177,000 | 2,786,000 | 2,380,000 | 2,263,000 | 3,316,000 | 4,474,000 | 6,320,000 | 6,698,000 | 7,496,000 | 7,536,000 | 7,267,000 | 6,891,000 | 5,940,000 | 5,995,000 | 6,244,000 |
| Operating Profit | -1,052,000 | -947,000 | -805,000 | -622,000 | -34,000 | -943,000 | -1,938,000 | -2,369,000 | -3,486,000 | -2,990,000 | -2,098,000 | -2,078,000 | -1,402,000 | -1,353,000 | -2,018,000 |
| Interest Payable | 230,000 | 199,000 | 173,000 | 172,000 | 176,000 | 188,000 | 163,000 | 150,000 | 110,000 | 107,000 | 120,000 | 118,000 | 101,000 | 161,000 | 114,000 |
| Interest Receivable | 1,000 | 1,000 | 2,000 | 1,000 | 1,000 | 1,000 | 1,000 | 2,000 | |||||||
| Pre-Tax Profit | -1,282,000 | -1,146,000 | -978,000 | -794,000 | -210,000 | -1,338,000 | -2,101,000 | -2,518,000 | -3,595,000 | -3,095,000 | -2,217,000 | -2,195,000 | -1,524,000 | -1,513,000 | -2,130,000 |
| Tax | 1,000 | 12,000 | 9,000 | 51,000 | 74,000 | 100,000 | 142,000 | 135,000 | 144,000 | 111,000 | 102,000 | 103,000 | 45,000 | 142,000 | |
| Profit After Tax | -1,282,000 | -1,145,000 | -966,000 | -785,000 | -159,000 | -1,264,000 | -2,001,000 | -2,376,000 | -3,460,000 | -2,951,000 | -2,106,000 | -2,093,000 | -1,421,000 | -1,468,000 | -1,988,000 |
| Dividends Paid | |||||||||||||||
| Retained Profit | -1,282,000 | -1,145,000 | -967,000 | -798,000 | -159,000 | -1,270,000 | -2,022,000 | -2,381,000 | -3,460,000 | -2,951,000 | -2,106,000 | -2,093,000 | -1,421,000 | -1,468,000 | -1,988,000 |
| Employee Costs | 1,716,000 | 2,119,000 | 2,145,000 | 2,289,000 | 2,541,000 | 3,787,000 | 4,534,000 | 4,936,000 | 5,051,000 | 4,838,000 | 4,644,000 | 4,515,000 | 3,757,000 | 3,531,000 | 3,871,000 |
| Number Of Employees | 37 | 44 | 46 | 50 | 52 | 71 | 85 | 83 | 84 | 81 | 76 | 75 | 66 | 62 | |
| EBITDA* | -919,000 | -819,000 | -691,000 | -479,000 | 199,000 | -524,000 | -1,478,000 | -1,944,000 | -3,082,000 | -2,570,000 | -1,772,000 | -1,781,000 | -1,211,000 | -1,200,000 | -1,923,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 218,000 | 215,000 | 546,000 | 584,000 | 691,000 | 796,000 | 421,000 | 599,000 | 736,000 | 824,000 | 595,000 | 500,000 | 317,000 | 567,000 | 558,000 |
| Intangible Assets | 4,091,000 | 3,944,000 | 3,135,000 | 2,554,000 | 2,651,000 | 2,528,000 | 2,486,000 | 2,396,000 | 2,006,000 | 1,745,000 | 1,502,000 | 1,076,000 | 724,000 | 437,000 | 263,000 |
| Investments & Other | 146,000 | 121,000 | 282,000 | 279,000 | 157,000 | 296,000 | 147,000 | ||||||||
| Debtors (Due After 1 year) | 139,000 | 5,000 | |||||||||||||
| Total Fixed Assets | 4,309,000 | 4,159,000 | 3,681,000 | 3,138,000 | 3,342,000 | 3,324,000 | 2,907,000 | 2,995,000 | 2,742,000 | 2,569,000 | 2,097,000 | 1,576,000 | 1,041,000 | 1,004,000 | 821,000 |
| Stock & work in progress | 716,000 | 821,000 | 796,000 | 895,000 | 915,000 | 680,000 | 754,000 | 760,000 | 805,000 | 1,273,000 | 920,000 | 963,000 | 912,000 | 573,000 | 492,000 |
| Trade Debtors | 177,000 | 456,000 | 455,000 | 576,000 | 1,062,000 | 1,410,000 | 1,618,000 | 1,877,000 | 1,918,000 | 2,424,000 | 2,720,000 | 2,029,000 | 1,846,000 | 1,690,000 | 1,496,000 |
| Group Debtors | |||||||||||||||
| Misc Debtors | 622,000 | 703,000 | 333,000 | 361,000 | 906,000 | 972,000 | 306,000 | 541,000 | |||||||
| Cash | 705,000 | 471,000 | 413,000 | 853,000 | 908,000 | 580,000 | 219,000 | 582,000 | 575,000 | 2,934,000 | 1,459,000 | 667,000 | 752,000 | 699,000 | 1,480,000 |
| misc current assets | 87,000 | 155,000 | 106,000 | 137,000 | 327,000 | 509,000 | 526,000 | 107,000 | 125,000 | 140,000 | 118,000 | 114,000 | 102,000 | 95,000 | 148,000 |
| total current assets | 1,769,000 | 1,975,000 | 1,839,000 | 2,522,000 | 3,292,000 | 3,179,000 | 3,117,000 | 3,948,000 | 4,126,000 | 7,104,000 | 5,578,000 | 4,679,000 | 4,584,000 | 3,363,000 | 4,157,000 |
| total assets | 6,078,000 | 6,134,000 | 5,520,000 | 5,660,000 | 6,634,000 | 6,503,000 | 6,024,000 | 6,943,000 | 6,868,000 | 9,673,000 | 7,675,000 | 6,255,000 | 5,625,000 | 4,367,000 | 4,978,000 |
| Bank overdraft | 553,000 | 809,000 | |||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 173,000 | 507,000 | 298,000 | 201,000 | 381,000 | 346,000 | 613,000 | 1,007,000 | 1,265,000 | 676,000 | 644,000 | 969,000 | 729,000 | 453,000 | 432,000 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | 79,000 | 935,000 | 702,000 | 159,000 | 188,000 | 829,000 | 1,827,000 | 685,000 | 26,000 | ||||||
| hp & lease commitments | 58,000 | 52,000 | 46,000 | 41,000 | 32,000 | 33,000 | 4,000 | 29,000 | 37,000 | 30,000 | 18,000 | 5,000 | 4,000 | 8,000 | |
| other current liabilities | 624,000 | 981,000 | 1,134,000 | 1,174,000 | 1,785,000 | 1,604,000 | 2,032,000 | 1,407,000 | 1,501,000 | 2,847,000 | 2,477,000 | 2,015,000 | 1,514,000 | 773,000 | 1,331,000 |
| total current liabilities | 934,000 | 2,475,000 | 2,180,000 | 1,575,000 | 2,386,000 | 2,536,000 | 3,458,000 | 3,272,000 | 4,630,000 | 3,553,000 | 3,139,000 | 2,989,000 | 2,243,000 | 1,915,000 | 1,797,000 |
| loans | 3,330,000 | 2,138,000 | 2,512,000 | 2,534,000 | 1,712,000 | 2,070,000 | 2,008,000 | 971,000 | 68,000 | 1,100,000 | 1,059,000 | 1,003,000 | 1,359,000 | 2,670,000 | 2,608,000 |
| hp & lease commitments | 228,000 | 274,000 | 320,000 | 4,000 | 34,000 | 50,000 | 31,000 | 7,000 | |||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | 119,000 | 177,000 | 352,000 | ||||||||||||
| provisions | 142,000 | 128,000 | 114,000 | 102,000 | 124,000 | 112,000 | 230,000 | 238,000 | 234,000 | 232,000 | 270,000 | 330,000 | 334,000 | 216,000 | 156,000 |
| total long term liabilities | 1,855,000 | 1,310,000 | 1,313,000 | 1,318,000 | 1,454,000 | 1,443,000 | 1,119,000 | 1,086,000 | 151,000 | 1,166,000 | 1,163,000 | 1,161,000 | 1,526,000 | 1,443,000 | 1,382,000 |
| total liabilities | 2,789,000 | 3,785,000 | 3,493,000 | 2,893,000 | 3,840,000 | 3,979,000 | 4,577,000 | 4,358,000 | 4,781,000 | 4,719,000 | 4,302,000 | 4,150,000 | 3,769,000 | 3,358,000 | 3,179,000 |
| net assets | 3,289,000 | 2,349,000 | 2,027,000 | 2,767,000 | 2,794,000 | 2,524,000 | 1,447,000 | 2,585,000 | 2,087,000 | 4,954,000 | 3,365,000 | 2,105,000 | 1,856,000 | 1,009,000 | 1,799,000 |
| total shareholders funds | 3,289,000 | 2,349,000 | 2,027,000 | 2,767,000 | 2,794,000 | 2,524,000 | 1,447,000 | 2,585,000 | 2,087,000 | 4,954,000 | 3,365,000 | 2,105,000 | 1,856,000 | 1,009,000 | 1,799,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | -1,052,000 | -947,000 | -805,000 | -622,000 | -34,000 | -943,000 | -1,938,000 | -2,369,000 | -3,486,000 | -2,990,000 | -2,098,000 | -2,078,000 | -1,402,000 | -1,353,000 | -2,018,000 |
| Depreciation | 61,000 | 39,000 | 74,000 | 103,000 | 149,000 | 246,000 | 265,000 | 282,000 | 257,000 | 256,000 | 217,000 | 177,000 | 131,000 | 114,000 | 55,000 |
| Amortisation | 72,000 | 89,000 | 40,000 | 40,000 | 84,000 | 173,000 | 195,000 | 143,000 | 147,000 | 164,000 | 109,000 | 120,000 | 60,000 | 39,000 | 40,000 |
| Tax | 1,000 | 12,000 | 9,000 | 51,000 | 74,000 | 100,000 | 142,000 | 135,000 | 144,000 | 111,000 | 102,000 | 103,000 | 45,000 | 142,000 | |
| Stock | -105,000 | 25,000 | -99,000 | -20,000 | 235,000 | -74,000 | -6,000 | -45,000 | -468,000 | 353,000 | -43,000 | 51,000 | 339,000 | 81,000 | 492,000 |
| Debtors | -279,000 | 1,000 | -121,000 | -625,000 | -209,000 | -208,000 | -881,000 | -122,000 | -141,000 | -319,000 | 146,000 | 117,000 | 822,000 | -41,000 | 2,037,000 |
| Creditors | -334,000 | 209,000 | 97,000 | -180,000 | 35,000 | -267,000 | -394,000 | -258,000 | 589,000 | 32,000 | -325,000 | 240,000 | 276,000 | 21,000 | 432,000 |
| Accruals and Deferred Income | -357,000 | -153,000 | -40,000 | -611,000 | 181,000 | -428,000 | 625,000 | -94,000 | -1,346,000 | 370,000 | 462,000 | 501,000 | 741,000 | -558,000 | 1,331,000 |
| Deferred Taxes & Provisions | 14,000 | 14,000 | 12,000 | -22,000 | 12,000 | -118,000 | -8,000 | 4,000 | 2,000 | -38,000 | -60,000 | -4,000 | 118,000 | 60,000 | 156,000 |
| Cash flow from operations | -1,212,000 | -774,000 | -390,000 | -638,000 | 452,000 | -981,000 | -268,000 | -1,983,000 | -3,093,000 | -2,096,000 | -1,687,000 | -1,110,000 | -1,134,000 | -1,672,000 | -2,391,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 25,000 | -161,000 | 3,000 | 122,000 | -139,000 | 149,000 | 147,000 | ||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | -856,000 | 233,000 | 543,000 | -29,000 | 188,000 | -829,000 | -998,000 | 1,827,000 | -685,000 | 659,000 | 26,000 | ||||
| Long term loans | 1,192,000 | -374,000 | -22,000 | 822,000 | -358,000 | 62,000 | 1,037,000 | 903,000 | -1,032,000 | 41,000 | 56,000 | -356,000 | -1,311,000 | 62,000 | 2,608,000 |
| Hire Purchase and Lease Commitments | 6,000 | -222,000 | -41,000 | -37,000 | 319,000 | 29,000 | -29,000 | -38,000 | -9,000 | 31,000 | 37,000 | 12,000 | -4,000 | -4,000 | 8,000 |
| other long term liabilities | -58,000 | 177,000 | -352,000 | 352,000 | |||||||||||
| share issue | |||||||||||||||
| interest | -230,000 | -199,000 | -173,000 | -172,000 | -176,000 | -188,000 | -163,000 | -149,000 | -109,000 | -105,000 | -119,000 | -117,000 | -100,000 | -160,000 | -112,000 |
| cash flow from financing | 2,276,000 | 1,082,000 | 534,000 | 1,355,000 | 50,000 | 2,602,000 | 900,000 | 2,597,000 | 1,270,000 | 4,507,000 | 3,340,000 | 1,881,000 | 168,000 | 1,235,000 | 6,317,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 234,000 | 58,000 | -440,000 | -55,000 | 328,000 | 361,000 | -363,000 | 7,000 | -2,359,000 | 1,475,000 | 792,000 | -85,000 | 53,000 | -781,000 | 1,480,000 |
| overdraft | -553,000 | -256,000 | 809,000 | ||||||||||||
| change in cash | 234,000 | 58,000 | -440,000 | -55,000 | 881,000 | 617,000 | -1,172,000 | 7,000 | -2,359,000 | 1,475,000 | 792,000 | -85,000 | 53,000 | -781,000 | 1,480,000 |
deltex medical group plc Credit Report and Business Information
Deltex Medical Group Plc Competitor Analysis
Perform a competitor analysis for deltex medical group plc by selecting its closest rivals, whether from the MANUFACTURING sector, other small companies, companies in PO19 area or any other competitors across 12 key performance metrics.
deltex medical group plc Ownership
DELTEX MEDICAL GROUP PLC group structure
Deltex Medical Group Plc has 1 subsidiary company.
deltex medical group plc directors
Deltex Medical Group Plc currently has 4 directors. The longest serving directors include Mr Nigel Keen (Mar 2000) and Mr Christopher Jones (Jun 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nigel Keen | 78 years | Mar 2000 | - | Director | |
| Mr Christopher Jones | 58 years | Jun 2015 | - | Director | |
| Mrs Natalie Wettler | 42 years | May 2021 | - | Director | |
| Mr Benjamin Carswell | United Kingdom | 50 years | Dec 2023 | - | Director |
P&L
December 2023turnover
1.8m
-28%
operating profit
-1.1m
+11%
gross margin
63.4%
-14.51%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
3.3m
+0.4%
total assets
6.1m
-0.01%
cash
705k
+0.5%
net assets
Total assets minus all liabilities
deltex medical group plc company details
company number
03902895
Type
Public limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
January 2000
age
25
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
chalkgrove plc (March 2000)
accountant
-
auditor
COOPER PARRY GROUP LIMITED
address
deltex medical terminus road, chichester, west sussex, PO19 8TX
Bank
NATIONAL WESTMINSTER BANK PLC
Legal Advisor
-
deltex medical group plc Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to deltex medical group plc.
deltex medical group plc Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DELTEX MEDICAL GROUP PLC. This can take several minutes, an email will notify you when this has completed.
deltex medical group plc Companies House Filings - See Documents
| date | description | view/download |
|---|
